Rifampin
Athanor · official
C43H58N4O12 · 822.9 g/mol
IUPAC name: [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
Also called rifampicin, Rifadin, ansamycin, tuberculosis, RNA polymerase inhibitor
Names and identifiers
- IUPAC name
- [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
- Synonyms
- rifampicin, Rifadin, ansamycin
+ 40 more
tuberculosis, RNA polymerase inhibitor, Rifampicin, Rifaldazine, Rifamycin AMP, Rifaprodin, Rifoldin, Rifa, Rifampicinum, Riforal, Abrifam, Eremfat, L-5103 Lepetit, Rifaldin, Rifoldine, R/AMP, Rifampicina, Rifampicine, Ba 41166/E, Rifapiam, BA-41166E, NSC-113926, 3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV, DTXSID6021244, VJT6J7R4TR, [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate, NSC113926, L-5103-LEPETIT, L-5103, NIH-10782, 8-(4-Methylpiperazinyliminomethyl) rifamycin SV, BA-41166/E, 8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV, Rifomycin SV, 8-(N-(4-methyl-1-piperazinyl)formidoyl)-, CHEBI:28077, 2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-, 21-acetate, Rifampin (Rifampicin), (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1(4,7).0(5,28)]triaconta-1(28),1(29),2,4,9,19,21,25,27-nonaen-13-yl acetate, DTXCID301244, 3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV
- Molecular formula
- C43H58N4O12
- Empirical formula
- C43H58N4O12
- Molecular weight
- 822.9 g/mol
- Exact mass
- 822.40512
- CAS number
- 13292-46-1
- PubChem CID
- 135398735
- Canonical SMILES
- CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C)C
- Isomeric SMILES
- C[C@H]1/C=C/C=C(\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C=N/N5CCN(CC5)C)/C
- InChI
- InChI=1S/C43H58N4O12/c1-21-12-11-13-22(2)42(55)45-33-28(20-44-47-17-15-46(9)16-18-47)37(52)30-31(38(33)53)36(51)26(6)40-32(30)41(54)43(8,59-40)57-19-14-29(56-10)23(3)39(58-27(7)48)25(5)35(50)24(4)34(21)49/h11-14,19-21,23-25,29,34-35,39,49-53H,15-18H2,1-10H3,(H,45,55)/b12-11+,19-14+,22-13-,44-20+/t21-,23+,24+,25+,29-,34-,35+,39+,43-/m0/s1
- InChIKey
- JQXXHWHPUNPDRT-WLSIYKJHSA-N
- Molfile
Names, InChI and the identifiers from PubChem, retrieved 2026-10-14.
Physical properties
- Appearance
- Red-brown crystalline powder[1]
- Odor
- ODORLESS[1]
- Solubility in water
- In water, 1,400 mg/L at 25 °C[1]
2 values
From Hazardous Substances Data Bank (HSDB), the most authoritative source here.
Value As written Source – Freely soluble in chloroform, soluble in ethyl acetate and in methanol. [1] Hazardous Substances Data Bank (HSDB)cites Physicians Desk Reference. Montvale, NJ: Thomson PDR. p. 759 (2003) –shown In water, 1,400 mg/L at 25 °C [1] Hazardous Substances Data Bank (HSDB)cites Yalkowsky, S.H., He, Yan., Handbook of Aqueous Solubility Data: An Extensive Compilation of Aqueous Solubility Data for Organic Compounds Extracted from the AQUASOL dATAbASE. CRC Press LLC, Boca Raton, FL. 2003., p. 1261 - log P
- log Kow = 4.24 (estimated)[1]
- Vapor pressure
- 3.1 × 10⁻³⁴ mmHg at 25 °C (estimated)[1]
Each value as its source reports it, with the source's number after it (listed under References). Where several sources report a property, the row shows the value most of them agree on, the rule the app uses; open the values to see every one.
Calculated
- Heavy atoms
- 59
- Rings
- 5
- Aromatic rings
- 2
- Fraction sp³ carbons (Fsp3)
- 0.53
- H-bond donors
- 6
- H-bond acceptors
- 15
- Rotatable bonds
- 4 computed here · PubChem 5
- TPSA (Ų)
- 220.1 computed here · PubChem 220
- Formal charge
- 0
- XLogP3
- 4.9 PubChem
- Complexity
- 1620 PubChem
- Stereocenters
- 9 definedCIP: C3: S · C7: S · C37: S · C39: S · C41: R · C43: R · C45: R · C47: S · C52: R
- Double-bond geometry
- C4=C5: E · C19=N20: E · C32=C34: Z · C35=C36: E
- Point group
- C1 of one 3D conformer with its hydrogens, by Athanor’s engine (as in the app)
Elemental analysis
- C62.76%
- H7.10%
- N6.81%
- O23.33%
Isotope pattern
Each peak is a nominal mass with its abundance-weighted exact mass, as a percentage of the tallest, from IUPAC natural isotope abundances.
Computed from the structure with RDKit 2026.09 when this page was built, beside PubChem's own computed values from its record; where the two differ, both are shown.
Predicted
- log P
- 4.34 Crippen (Wildman and Crippen 1999)
- log S (water solubility)
- -7.54 ESOL (Delaney 2004), log mol/L
- Synthetic accessibility
- 7.09 SA score, 1 easy to 10 hard (Ertl and Schuffenhauer 2009)
Drug-likeness: Lipinski’s rule of five
- Molecular weight ≤ 500: 822.95
- log P ≤ 5 (Crippen): 4.34
- H-bond donors ≤ 5: 6
- H-bond acceptors ≤ 10: 15
Breaks 3 of the four rules.
¹³C NMR shifts, predicted
Predictions, not measurements; each names its method. A measured log P, where a source reports one, is under Physical properties.
Safety
Warning
Most widely reported: 61 company reports to ECHA. Source [2].
Harmful or irritant
- H302Harmful if swallowed (98.4% of reports)
- H315Causes skin irritation (85.2% of reports)
- H319Causes serious eye irritation (85.2% of reports)
- H335May cause respiratory irritation (83.6% of reports)
Precautionary statements: P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, P501
Storage
- Rifampin capsules should be stored in tight, light-resistant containers at a temperature of 30 °C or less, preferably between 15-30 °C. The capsules should not be exposed to excessive heat.[1]
Safety data sheets on the supplier’s page: MedChemexpress MCE, Sigma-Aldrich, Alfa Chemistry.
Always read the supplier’s safety data sheet before working with it.
Spectra
- 13C NMRSpectraBase
- GC-MSSpectraBase
- MS-MSNIST Mass Spectrometry Data Center (IT/ion trap)
- LC-MSMassBank Europe (Exploris 480 Orbitrap (Thermo Scientific) · LC-ESI-QFT · POSITIVE) · MassBank Europe (Exploris 480 Orbitrap (Thermo Scientific) · LC-ESI-QFT · POSITIVE) · MassBank Europe (Exploris 480 Orbitrap (Thermo Scientific) · LC-ESI-QFT · NEGATIVE) · MassBank Europe (micrOTOF-Q · LC-ESI-QTOF · POSITIVE) · MassBank Europe (micrOTOF-Q · LC-ESI-QTOF · POSITIVE) · MassBank Europe (micrOTOF-Q · LC-ESI-QTOF · POSITIVE)
- UVHazardous Substances Data Bank (HSDB)
- FTIRSpectraBase (KBr WAFER)
- ATR-IRSpectraBase (Bio-Rad FTS · ATR-Neat (DuraSamplIR II))
Experimental spectra held by these sources; each link opens the source's own record.
Literature
Reading PubChem, OpenAlex and GSRS…
Bioactivity
Reading ChEMBL…
References
- [1]Hazardous Substances Data Bank (HSDB) · Public domain (US NLM) · via PubChem · retrieved 2026-10-14
- [2]European Chemicals Agency (ECHA) · ECHA legal notice: reuse with acknowledgement · via PubChem · retrieved 2026-10-14
- [3]SpectraBase · Linked only · via PubChem · retrieved 2026-10-14
- [4]NIST Mass Spectrometry Data Center · Linked only · via PubChem · retrieved 2026-10-14
- [5]MassBank Europe · Linked only · via PubChem · retrieved 2026-10-14
- [6]MassBank of North America (MoNA) · CC BY 4.0 · via PubChem · retrieved 2026-10-14
- ·Calculated values: computed by Athanor with RDKit 2026.09 from the structure.
- ·Literature on PubChem
Data last updated 2026-10-14.
